3 ms·

This reminds me of the company Loyal - a startup aiming at medical approaches to longevity by first treating pets/dogs. It's easier (I assume) from a regulatio

This reminds me of the company Loyal - a startup aiming at medical approaches to longevity by first treating pets/dogs. It's easier (I assume) from a regulation/moral standpoint to test therapies on animals instead of humans. I wonder if developing therapies for animal cancers first could be profitable, to bring in investment and prove a theory, and then expand to humans in a similar way.

jghn 2y ago
> It's easier (I assume) from a regulation You'd be surprised. One of their larger challenges has been that the regulatory environment is very murky. It's definitely not anything goes, but it's not as well roadmapped as it is for human drugs.